Lymphatic endothelial tumors induced by intraperitoneal injection of incomplete Freund's adjuvant. 1999

S Mancardi, and G Stanta, and N Dusetti, and M Bestagno, and L Jussila, and M Zweyer, and G Lunazzi, and D Dumont, and K Alitalo, and O R Burrone
International Centre for Genetic Engineering and Biotechnology (ICGEB), Area Science Park, Padriciano 99, Trieste, 34012, Italy.

Endothelial cells form the inner lining of blood and lymphatic vessels. In mice, only tumors of the blood vessel endothelium (haemangiomas) have been thus far reported. Here we describe a highly reproducible method for the induction of benign tumors of the lymphatic endothelial cells (lymphangiomas) in mice by intraperitoneal injection of incomplete Freund's adjuvant. Morphological and histopathological studies of the lesions revealed the presence of cells at various levels of vascular development. The lymphangiomas developed in the peritoneal cavity and expressed the endothelial markers CD31/PECAM (platelet endothelial cell adhesion molecule), CD54/ICAM-1 (InterCellular Adhesion Molecule-1), and CD102/ICAM-2, as well as the vascular endothelial growth factor (VEGF) receptor Flk-1, the endothelial cell specific receptors Tie-1 and Tie-2 and the lymphatic endothelial cell specific Flt4 receptor as shown by in situ hybridization. The Flk-1 and Flt4 receptors were also identified in immunoblots of the tumors and in cells cultured from them. When induced in beta-galactosidase knock-in Flt4(+/-) mice, the tumor endothelia could be stained blue in a number of tumor cells although the staining was of lower intensity than in normal lymphatic vessels. The tumor-derived cells could be propagated in vitro and they spontaneously differentiated, forming vessel-like structures. Murine lymphangiomas thus represent a highly reproducible and convenient source of lymphatic endothelial cells.

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D008202 Lymphangioma A benign tumor resulting from a congenital malformation of the lymphatic system. Lymphangioendothelioma is a type of lymphangioma in which endothelial cells are the dominant component. Lymphangioendothelioma,Lymphangioma, Cavernous,Endothelioma, Lymphatic,Cavernous Lymphangioma,Cavernous Lymphangiomas,Endotheliomas, Lymphatic,Lymphangioendotheliomas,Lymphangiomas,Lymphangiomas, Cavernous,Lymphatic Endothelioma,Lymphatic Endotheliomas
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008808 Mice, Inbred CBA An inbred strain of mouse that is widely used in BIOMEDICAL RESEARCH. Mice, CBA,Mouse, CBA,Mouse, Inbred CBA,CBA Mice,CBA Mice, Inbred,CBA Mouse,CBA Mouse, Inbred,Inbred CBA Mice,Inbred CBA Mouse
D010534 Peritoneal Neoplasms Tumors or cancer of the PERITONEUM. Peritoneal Carcinomatosis,Peritoneal Surface Malignancy,Carcinomatosis, Peritoneal,Malignancy, Peritoneal Surface,Neoplasm, Peritoneal,Peritoneal Carcinomatoses,Peritoneal Neoplasm,Peritoneal Surface Malignancies,Surface Malignancy, Peritoneal
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D004729 Endothelium, Lymphatic Unbroken cellular lining (intima) of the lymph vessels (e.g., the high endothelial lymphatic venules). It is more permeable than vascular endothelium, lacking selective absorption and functioning mainly to remove plasma proteins that have filtered through the capillaries into the tissue spaces. Lymphatic Endothelium,Endotheliums, Lymphatic,Lymphatic Endotheliums

Related Publications

S Mancardi, and G Stanta, and N Dusetti, and M Bestagno, and L Jussila, and M Zweyer, and G Lunazzi, and D Dumont, and K Alitalo, and O R Burrone
August 1995, Journal of gastroenterology,
S Mancardi, and G Stanta, and N Dusetti, and M Bestagno, and L Jussila, and M Zweyer, and G Lunazzi, and D Dumont, and K Alitalo, and O R Burrone
June 2000, Journal of immunology (Baltimore, Md. : 1950),
S Mancardi, and G Stanta, and N Dusetti, and M Bestagno, and L Jussila, and M Zweyer, and G Lunazzi, and D Dumont, and K Alitalo, and O R Burrone
June 1963, Nature,
S Mancardi, and G Stanta, and N Dusetti, and M Bestagno, and L Jussila, and M Zweyer, and G Lunazzi, and D Dumont, and K Alitalo, and O R Burrone
January 1993, Arthritis and rheumatism,
S Mancardi, and G Stanta, and N Dusetti, and M Bestagno, and L Jussila, and M Zweyer, and G Lunazzi, and D Dumont, and K Alitalo, and O R Burrone
July 1998, Advanced drug delivery reviews,
S Mancardi, and G Stanta, and N Dusetti, and M Bestagno, and L Jussila, and M Zweyer, and G Lunazzi, and D Dumont, and K Alitalo, and O R Burrone
January 2012, Journal of immunotherapy (Hagerstown, Md. : 1997),
S Mancardi, and G Stanta, and N Dusetti, and M Bestagno, and L Jussila, and M Zweyer, and G Lunazzi, and D Dumont, and K Alitalo, and O R Burrone
December 2012, Journal of immunological methods,
S Mancardi, and G Stanta, and N Dusetti, and M Bestagno, and L Jussila, and M Zweyer, and G Lunazzi, and D Dumont, and K Alitalo, and O R Burrone
January 1973, Acta dermato-venereologica,
S Mancardi, and G Stanta, and N Dusetti, and M Bestagno, and L Jussila, and M Zweyer, and G Lunazzi, and D Dumont, and K Alitalo, and O R Burrone
August 1982, Experimental parasitology,
S Mancardi, and G Stanta, and N Dusetti, and M Bestagno, and L Jussila, and M Zweyer, and G Lunazzi, and D Dumont, and K Alitalo, and O R Burrone
April 1968, The Journal of pathology and bacteriology,
Copied contents to your clipboard!